Executive Order 14273: Lowering Drug Prices by Once Again Putting Americans First

What the order contains

Section headings exactly as they appear in the official text.

• Sec. 1. Purpose
• Sec. 2. Policy
• Sec. 3. Improving upon the Inflation Reduction Act
• Sec. 4. Reducing the Prices of High-Cost Drugs for Seniors
• Sec. 5. Appropriately Accounting for Acquisition Costs of Drugs in Medicare
• Sec. 6. Promoting Innovation, Value, and Enhanced Oversight in Medicaid Drug Payment
• Sec. 7. Access to Affordable Life-Saving Medications
• Sec. 8. Reevaluating the Role of Middlemen
• Sec. 9. Accelerating Competition for High-Cost Prescription Drugs
• Sec. 10. Increasing Prescription Drug Importation to Lower Prices
• Sec. 11. Reducing Costly Care for Seniors
• Sec. 12. Improving Transparency into Pharmacy Benefit Manager Fee Disclosure
• Sec. 13. Combating Anti-Competitive Behavior by Prescription Drug Manufacturers
• Sec. 14. General Provisions

Section 1, quoted from the order

Verbatim text from the signed document. These are the words of the document, not SaveYourState’s.

My first term included numerous significant actions, including some of the most aggressive in recent history, to deliver lower prescription drug prices to American patients. The message was clear: no longer would the executive branch sit idly by as pharmaceutical manufacturers charged patients in our Nation more than those in other countries for the exact same prescription drugs, often made in the exact same places. These actions included encouraging the development of generic and biosimilar alternatives to higher cost brand name prescription drugs and biologics to harness competitive forces and increase access to affordable medicines. The United States also, for the first time, established a pathway to expand access to lower cost drugs imported from outside of the country. […]

Federal Register notes

See: EO 14297, May 12, 2025